The patient is a 65-year-old recently retired schoolteacher named Jennifer Albertson; I diagnosed her with Hyperthyroidism. The Plan is to start her on Methimazole 10 mg by mouth daily and Propanolol 20 mg by mouth every 8 hours. discussed other options like thyroid medication ablation with radioactive iodine or surgical resection. Reflection: Address the following questions: Both the diagnostic testing and treatments available for this client’s diagnosis can be very expensive. How would your treatment plan change if your client did not have insurance? What resources are available in your area to support a client with these diagnostic and treatment needs? Include the following components: write 150-300 words in a Microsoft Word document demonstrating clinical judgment appropriate to the virtual patient scenario cite at least one relevant scholarly source as defined by program expectations, and communicate with minimal errors in English grammar, spelling, syntax, and punctuation
The case presented is of a 65-year-old patient named Jennifer, who was a school teacher but is now retired. I diagnosed Jennifer with hyperthyroidism, also known as overactive thyroid. Hyperthyroidism is a condition characterized by the overproduction of the thyroid hormone, which speeds up a person’s metabolism (Hyperthyroidism (overactive thyroid) – NIDDK n.d). I plan on Starting Jennifer on Methimazole 10 mg by mouth daily and Propanolol 20 mg by mouth every 8 hours. However, we also discussed other options like thyroid medication ablation with radioactive iodine or surgical resection.
Nevertheless, if Jennifer was without insurance, addressing her hyperthyroidism would require a thoughtful approach to effectively managing diagnostic testing and treatment expenses. First, we would opt for cost-effective yet reliable diagnostic testing options. Initial tests, including a thyroid function panel with TSH, T3, and T4 levels, would be prioritized (Lane et al., 2020). Seeking out community clinics or local health departments in her area offering reduced-cost or sliding-scale fee options for these tests would be helpful.
For the treatment plan, we would explore generic versions of Methimazole and Propranolol, known medications for hyperthyroidism, as they are commonly more budget-friendly. Additionally, dosing would be adjusted cautiously, starting with lower doses and monitoring Jennifer’s response closely (Bartalena et al., 2022). Consistently, regular follow-up appointments are crucial for monitoring progress but can strain finances. I would, therefore, inform Jennifer about local programs that assist uninsured individuals, which can help offset costs for medications and necessary medical visits (Bartalena et al., 2022).
Furthermore, exploring financial assistance options from non-profit organizations and patient advocacy groups would be another avenue (Lane et al., 2020). Some entities provide grants or support for individuals requiring medical treatment. Following this, patient education is a cornerstone of this adjusted plan. Jennifer would be educated about her condition and how lifestyle changes, such as dietary modifications, could complement her treatment, potentially reducing her reliance on medication (Bartalena et al., 2022). Finally, while Jennifer might be presented with options like radioactive iodine ablation or surgical resection, it’s imperative to weigh the financial implications and potential complications carefully. Exploring alternative treatments and seeking second opinions from specialists could unveil more budget-friendly solutions (Lane et al., 2020).
In conclusion, the absence of insurance can present financial challenges. By adopting a comprehensive approach that combines cost-effective testing, affordable medications, financial assistance programs, patient education, and careful consideration of treatment options, Jennifer can still receive the necessary care for her hyperthyroidism without jeopardizing her financial well-being.
References
Bartalena, L., Piantanida, E., Gallo, D., Ippolito, S., & Tanda, M. L. (2022). Management of Graves’ hyperthyroidism: Present and future. Expert Review of Endocrinology & Metabolism, 17(2), 153-166. https://doi.org/10.1080/17446651.2022.2052044
Lane, L. C., Cheetham, T. D., Perros, P., & Pearce, S. H. (2020). New therapeutic horizons for Graves’ hyperthyroidism. Endocrine Reviews, 41(6), 873-884. https://doi.org/10.1210/endrev/bnaa022
U.S. Department of Health and Human Services. (n.d.). Hyperthyroidism (overactive thyroid) – NIDDK. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/endocrine-diseases/hyperthyroidism